However, EP3 expression was not compared between healthy tissue and tumor – published studies have shown a downregulation of EP3 in breast cancer compared to healthy breast tissue [8], in colon cancer [22] and in prostate cancer [23]. This evidence concerns the gene PTGER3 and prostate carcinoma.